Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases.
Ferhat DemirÖzlem Akgün DoğanYasemin Kendir DemirkolKübra Ermiş TekkuşSezin CanbekSerife Gül KaradagHafize Emine SönmezNuray Aktay AyazHamdi Levent DoganayBetül SözeriPublished in: Clinical rheumatology (2020)
The classification criteria described for SAIDs so far unfortunately do not cover all patients with signs of periodic fevers. The NGS gene panel appears to be a useful diagnostic tool for some of the patients with clinically unclassified SAID findings. Key Points • The classification criteria described for SAIDs do not cover all patients with signs of periodic fevers • The use of the undefined SAID nomenclature will benefit clinicians for diagnosis and initiating early treatment • The NGS panel appears to be a useful diagnostic tool in patients with clinically unclassified SAIDs.